BioMarin Pharmaceutical
BMRN
#1442
Rank
NZ$20.60 B
Marketcap
$108.10
Share price
-3.32%
Change (1 day)
-25.14%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): NZ$0.63 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are NZ$2.75 Billion. In 2023 the company made an earning of NZ$0.32 Billion, an increase over its 2022 earnings that were of NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.63 B97.91%
2023 NZ$0.32 B26.07%
2022 NZ$0.25 B-298.51%
2021 -NZ$0.13 Billion78.04%
2020 -NZ$72.14 Million-55.36%
2019 -NZ$0.17 Billion-33.56%
2018 -NZ$0.25 Billion297.78%
2017 -NZ$61.15 Million-95.68%
2016 -NZ$1.42 Billion437.12%
2015 -NZ$0.27 Billion23.91%
2014 -NZ$0.22 Billion-29.25%
2013 -NZ$0.31 Billion49.23%
2012 -NZ$0.21 Billion171.11%
2011 -NZ$74.37 Million103.01%
2010 -NZ$36.63 Million-3903.54%
2009 NZ$0.96 M-98.31%
2008 NZ$56.97 M-189.7%
2007 -NZ$63.52 Million51.02%
2006 -NZ$42.06 Million-61.58%
2005 -NZ$0.11 Billion-56.59%
2004 -NZ$0.26 Billion95.13%
2003 -NZ$0.13 Billion12.09%
2002 -NZ$0.12 Billion73.19%
2001 -NZ$66.56 Million18.32%
2000 -NZ$56.26 Million19.65%
1999 -NZ$47.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.89 Billion-232.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.36 Billion-152.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$69.37 Million-110.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.62 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-NZ$0.18 Billion-125.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.15 B-76.10%๐Ÿ‡บ๐Ÿ‡ธ USA